Legal & General Group Plc - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$2,283,142
-59.2%
243,665
+6.9%
0.00%
-50.0%
Q2 2023$5,592,422
+8.2%
227,983
+2.6%
0.00%0.0%
Q1 2023$5,170,641
-8.1%
222,202
-0.1%
0.00%0.0%
Q4 2022$5,627,400
+33.6%
222,339
+1.8%
0.00%0.0%
Q3 2022$4,212,000
-22.8%
218,438
+2.0%
0.00%0.0%
Q2 2022$5,457,000
+283.8%
214,257
+287.6%
0.00%
Q1 2022$1,422,000
-38.2%
55,275
+0.6%
0.00%
-100.0%
Q4 2021$2,301,000
-2.0%
54,960
+1.9%
0.00%0.0%
Q3 2021$2,347,000
+11.1%
53,934
+20.7%
0.00%0.0%
Q2 2021$2,113,000
+45.7%
44,680
+57.8%
0.00%0.0%
Q1 2021$1,450,000
+49.9%
28,309
-21.7%
0.00%
Q4 2020$967,000
+3.2%
36,160
+32.5%
0.00%
Q3 2020$937,000
-19.5%
27,285
-4.1%
0.00%
-100.0%
Q2 2020$1,164,000
+2884.6%
28,445
+2419.5%
0.00%
Q1 2020$39,000
+105.3%
1,129
-23.8%
0.00%
Q4 2019$19,0001,4820.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$14,609,16117.42%
SB INVESTMENT ADVISERS (UK) LTD 16,684,041$156,329,4641.29%
Octagon Capital Advisors LP 325,050$3,045,7190.47%
SECTOR GAMMA AS 148,538$1,391,8010.36%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 1,345,635$12,608,6000.31%
ALGERT GLOBAL LLC 449,685$4,2140.20%
Quantamental Technologies LLC 18,519$173,5230.16%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 47,000$439,9200.15%
DUALITY ADVISERS, LP 123,871$1,160,6710.14%
Empowered Funds, LLC 385,135$3,608,7150.11%
View complete list of VIR BIOTECHNOLOGY INC shareholders